Search research articles
Contact Us
Filters
Showing results (21-30 of 160) with videos related to
Page
of 16
Sort By:
The Breast Journal
|
April 27, 2019
Central nervous system metastases in triple-negative breast cancer: A step in the right direction
Aditya Shreenivas, Charles L Shapiro
Oncology (Williston Park, N.Y.)
|
May 31, 2018
Improving Adherence to Endocrine Therapy in Women With HR-Positive Breast Cancer
Julia P Brockway, Charles L Shapiro
JAMA Oncology
|
December 2, 2017
Zoledronic Acid Dosing in Patients With Metastatic Breast Cancer
Charles L Shapiro, Andrew L Himelstein
Oncology (Williston Park, N.Y.)
|
September 17, 2016
Ready, Fire, Aim: Addressing Issues Associated With Multigene Panel Testing for Cancer Susceptibility
Sherry R Boyar, Charles L Shapiro
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2020
Reply to E. Gonzalez-Rodriguez et al
Charles L Shapiro, Christina Lacchetti, Joan Neuner
Seminars in Oncology
|
December 10, 2003
Second cancers after breast cancer treatment
Sister Mary Andrew Matesich, Charles L Shapiro
Expert Review of Anticancer Therapy
|
August 30, 2013
The challenges of individualized care for older patients with localized breast cancer
Ewa Mrózek, Stephen P Povoski, Charles L Shapiro
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2018
Reply to L. Kennedy et al
Charles L Shapiro, James P Moriarty, Bijan Borah
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2012
Bone health in adult cancer survivorship
Maryam B Lustberg, Raquel E Reinbolt, Charles L Shapiro
The Lancet. Oncology
|
August 1, 2017
Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?
Bennett E Levis, Phillip F Binkley, Charles L Shapiro
Page
of 16
Search research articles
Search
Showing results (21-30 of 160) with videos related to
Sort By:
Page
of 16
The Breast Journal
|
April 27, 2019
Central nervous system metastases in triple-negative breast cancer: A step in the right direction
Aditya Shreenivas, Charles L Shapiro
Oncology (Williston Park, N.Y.)
|
May 31, 2018
Improving Adherence to Endocrine Therapy in Women With HR-Positive Breast Cancer
Julia P Brockway, Charles L Shapiro
JAMA Oncology
|
December 2, 2017
Zoledronic Acid Dosing in Patients With Metastatic Breast Cancer
Charles L Shapiro, Andrew L Himelstein
Oncology (Williston Park, N.Y.)
|
September 17, 2016
Ready, Fire, Aim: Addressing Issues Associated With Multigene Panel Testing for Cancer Susceptibility
Sherry R Boyar, Charles L Shapiro
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2020
Reply to E. Gonzalez-Rodriguez et al
Charles L Shapiro, Christina Lacchetti, Joan Neuner
Seminars in Oncology
|
December 10, 2003
Second cancers after breast cancer treatment
Sister Mary Andrew Matesich, Charles L Shapiro
Expert Review of Anticancer Therapy
|
August 30, 2013
The challenges of individualized care for older patients with localized breast cancer
Ewa Mrózek, Stephen P Povoski, Charles L Shapiro
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2018
Reply to L. Kennedy et al
Charles L Shapiro, James P Moriarty, Bijan Borah
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2012
Bone health in adult cancer survivorship
Maryam B Lustberg, Raquel E Reinbolt, Charles L Shapiro
The Lancet. Oncology
|
August 1, 2017
Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?
Bennett E Levis, Phillip F Binkley, Charles L Shapiro
Page
of 16